Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 3-year average of -67.24%, near the high end of its 3-year range (-5773.71%–40.56%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 500 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Artiva Biotherapeutics, Inc.
Market Cap
$348.59M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$348.85M
Operating Margin
24.85%
TTM Avg
23.00%
3Y Avg
24.99%
5Y Avg
31.17%
Market Cap
$345.48M
Operating Margin
-65.36%
TTM Avg
-64.13%
3Y Avg
-75.36%
5Y Avg
-72.00%
Market Cap
$339.15M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$361.64M
Operating Margin
-271.90%
TTM Avg
-418.31%
3Y Avg
-211.58%
5Y Avg
-783.53%
Market Cap
$363.54M
Operating Margin
-18.00%
TTM Avg
-67.22%
3Y Avg
-104.89%
5Y Avg
-90.63%
Market Cap
$366.39M
Operating Margin
-130.65%
TTM Avg
-155.28%
3Y Avg
-156.88%
5Y Avg
-129.07%
Market Cap
$330.60M
Operating Margin
-290.68%
TTM Avg
-313.41%
3Y Avg
-428.31%
5Y Avg
-345.79%
Market Cap
$329.01M
Operating Margin
-188.25%
TTM Avg
-178.83%
3Y Avg
-158.00%
5Y Avg
-158.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | $348.59M | 0.00% | 0.00% | 0.00% | N/A |
| Embecta Corp. (EMBC)vs › | $348.85M | 24.85% | 23.00% | 24.99% | 31.17% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | -65.36% | -64.13% | -75.36% | -72.00% |
| Cabaletta Bio, Inc. (CABA)vs › | $339.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -271.90% | -418.31% | -211.58% | -783.53% |
| Agenus Inc. (AGEN)vs › | $363.54M | -18.00% | -67.22% | -104.89% | -90.63% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | -130.65% | -155.28% | -156.88% | -129.07% |
| C4 Therapeutics, Inc. (CCCC)vs › | $330.60M | -290.68% | -313.41% | -428.31% | -345.79% |
| CapsoVision, Inc. (CV)vs › | $329.01M | -188.25% | -178.83% | -158.00% | -158.00% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | -14.22% | -4.51% | -387.94% | -2012.06% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -5773.71% |
| 2023-12-31 | -509.36% |
| 2023-09-30 | 40.56% |
| 2023-06-30 | -338.12% |
| 2023-03-31 | -1788.47% |
